GSK Poaches AstraZeneca’s Sheldon to Boost Pharma Dealmaking

GSK Plc has hired AstraZeneca Plc executive Chris Sheldon for a senior business development role as the British company seeks to boost its pharmaceutical pipeline, people with knowledge of the matter said.

Sheldon is set to join GSK after nearly two decades at AstraZeneca, the people said, asking not to be identified because the information is private.

He started at AstraZeneca as a research scientist and eventually became global head of business development and licensing for oncology research and development, working on acquisitions and partnerships in this key area, his LinkedIn profile shows. Last year, Sheldon moved into a new ...